(Reuters) – Merck & Co said on Wednesday Chief Executive Officer Rob Davis would succeed Chairman Ken Frazier, taking on the additional role effective Dec. 1. Frazier, who has been …
merck’s
-
-
By Deena Beasley – Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious …
-
By Deena Beasley – Merck & Co’s new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-risk …
-
-Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment of chronic cough and sought additional information on the …
-
By Rocky Swift and Kantaro Komiya TOKYO – A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck & Co Inc, part of …
-
– Merck & Co said on Monday the U.S. Food and Drug Administration has placed clinical holds on trials testing the company’s HIV drug islatravir. The health regulator’s move is …
-
By Michael Erman and Manas Mishra – A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & …
-
By Manas Mishra and Michael Erman -Merck & Co said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less effective in …
-
By Pushkala Aripaka -Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and …